Actively hiring
Artificial Intelligence
Biotechnology
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$39.5M
1 round on record
Latest round
$39.5M
Venture round · Mar 2026 · 6 mo ago
Team
11-50
employees, estimated range
Backers
3
Angelini Ventures, Lumira Ventures
The money's age
Fresh money
6 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2026 | $39.5M | — | prnewswire.com |
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers

Nextmol develops computational chemistry and artificial intelligence solutions for chemical R&D. Discover the platform that L'Oreal and…

Rowan is a cloud-based computational chemistry platform for molecular property prediction, simulation, and protein–ligand complex modeling…

Streamline discovery with our integrated drug discovery platform, blending AI, physics-based tools, and wet lab for unparalleled…

Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict…

PARIMA builds the future of protein through advanced cell cultivation.

Gandeeva Therapeutics is a precision medicine company leveraging cryo-EM and machine learning for drug discovery.
News
Congruence Announces Participation at the 2026 Bloom Burton & Co. Healthcare Investor Conference
https://www.prnewswire.com/news-releases/congruence-announces-participation-at-the-2026-bloom-burton-co-healthcare-investor-conference-302747214.html The post Congruence Announces Participation at the 2026 Bloom Burton & Co. Healthcare Investor Conference
Read more
Report
Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare Conference
https://www.prnewswire.com/news-releases/congruence-announces-participation-in-the-25th-annual-needham-virtual-healthcare-conference-302738712.html?tc=eml_cleartime The post Congruence Announces Participation in the 25th Annual Needham Virtual Healthcare
Read more
Report
Congruence Announces $39.5M Financing to Advance Portfolio of Small Molecule Correctors into the Clinic
https://www.prnewswire.com/news-releases/congruence-announces-39-5m-financing-to-advance-portfolio-of-small-molecule-correctors-into-the-clinic-302718764.html?tc=eml_cleartime The post Congruence Announces $39.5M Financing to Advance Portfolio of Small Mo
Read more
Report
Congruence annonce un financement de 39,5 millions de dollars pour faire passer son portefeuille de correcteurs à petites molécules au stade clinique
Essai clinique de phase 1/1b en cours avec le CGX-926 pour l'obésité génétique liée à un déficit en MC4R Programmes sur la maladie de Parkinson et le déficit en alpha-1-antitrypsine avancent vers la phase clinique Montréal, Canada, le 19 mars 2026 - Congr
Read more
Report
Congruence Announces First Dosing in Phase 1/1b Clinical Trial of CGX-926, a First-in-Class Oral MC4R Corrector for Genetic Obesity
https://www.prnewswire.com/news-releases/congruence-announces-first-dosing-in-phase-11b-clinical-trial-of-cgx-926-a-first-in-class-oral-mc4r-corrector-for-genetic-obesity-302718759.html?tc=eml_cleartime The post Congruence Announces First Dosing in Phase
Read more
Report
Pro access
Upgrade to see all 25 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.
Financials
Total raised
$39.5M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2026 | $39.5M | Details |

Angelini Ventures
Lumira Ventures
OrbiMed